Views & Analysis
The landscape for UK R&D SMEs post-COVID
Big pharma might have dominated COVID headlines with its vaccine drive, but behind the scenes an army of SMEs has enabled the UK to respond swiftly to the pandemic.
Monday 30 March 2026
